1. Hoek, B. Van, Ph, D., Rooij, B. De, Verspaget, H. W., & Ph, D. (2012). Risk factors for infection after liver transplantation. Best Practice & Research Clinical Gastroenterology, 26(1), 61–72. http://doi.org/10.1016/j.bpg.2012.01.004 2. Kim, H. K., Park, Y. K., Wang, H., Kim, B. W., Shin, S. Y., Lim, S., & Choi, Y. H. (2013). Epidemiology and Clinical Features of Post-Transplant Bloodstream Infection : An Analysis of 222 Consecutive Liver Transplant Recipients. Infection and Chemotherapy, 45(3), 315–324. 3. Zhong, L., Men, T., Li, H., Peng, Z., & Gu, Y. (2012). Multidrug-resistant gram-negative bacterial infections after liver transplantation e Spectrum and risk factors. Journal of Infection, 64(3), 299–310. http://doi.org/10.1016/j.jinf.2011.12.005 4. Boletin GREBO. (2015). Infecciones micóticas en nuestros hospitales, (2027). 5. Pedersen, M., & Seetharam, A. (2014). Infections After Orthotopic Liver Transplantation. Journal of Clinical and Experimental Hepatology, 4(4), 347–360. http://doi.org/10.1016/j.jceh.2014.07.004 6. Vera, A., & Contreras, F. G. (2011). Incidence and risk factors for infections after liver transplant : single-center experience at the University ¤ n Santa Fe de Bogotá. Transplnat Infectious Disease, 13, 608–615. http://doi.org/10.1111/j.1399-3062.2011.00640.x 7. Song, S. H., Li, X. X., Wan, Q. Q., & Ye, Q. F. (2016). Risk Factors for Mortality in Liver Transplant Recipients With. Transplantation Proceedings, 3563(2014), 3560–3563. http://doi.org/10.1016/j.transproceed.2014.08.049 8. González, L., & Cortés, J. A. (2014). Revisión sistemática de la farmacorresistencia en enterobacterias de aislamientos hospitalarios en Colombia. Biomedica. 9. Navarro, F., & Miro, E. (2016). Lectura interpretada del antibiograma de enterobacterias. Enfermedades Infecciosas Y Microbiologia Clinica, 28(9), 638–645. http://doi.org/10.1016/j.eimc.2010.05.002 11. Oliveros, A., Uribe, N., Sierra, P., & Jaimes, F. (2015). Asociación Colombiana de Infectología Bacteriemia por enterobacterias resistentes a carbapenems. Un estudio transversal y Javier Mauricio González e. Infectio, 19(2), 60–66. 12. Qureshi, Z. A., Paterson, D. L., Potoski, B. A., Kilayko, M. C., Sandovsky, G., Sordillo, E., & Polsky, B. (2012). Treatment Outcome of Bacteriemia Due to KPC-Producing Klebsiella pneumoniae : Superiority of Combination Antimicrobial Regimens. Antimicrobial Agents and Chemotherapy, 56(4), 2108–2113. http://doi.org/10.1128/AAC.06268-11 13. Barchiesi, F., Montalti, R., Castelli, P., Nicolini, D., Staffolani, S., Mocchegiani, F., … Vivarelli, M. (2016). Carbapenem-Resistant Klebsiella pneumoniae influences the outcome of early infections in liver transplant recipients. BMC Infectious Diseases, 1–6. http://doi.org/10.1186/s12879-016-1876-5 14. Kalpoe, J. S., Sonnenberg, E., Factor, S. H., Martin, R., Schiano, T., Patel, G., & Huprikar, S. (2012). Mortality Associated With Carbapenem-Resistant Klebsiella pneumoniae Infections in Liver Transplant Recipients. Liver Transplantation, 18, 468–474. http://doi.org/10.1002/lt. 15. Pereira, M Scully, B. (2016). Risk Factors and Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Infections in Liver Transplant Recipients. Liver Transplantation, 21(12), 1511–1519. http://doi.org/10.1002/lt.24207.Risk 16. Tumbarello, M., Trecarichi, E. M., Rosa, F. G. De, Giannella, M., Giacobbe, D. R., Bassetti, M., … Antinfettiva, I. T. (2015). Infections caused by KPC-producing Klebsiella pneumoniae : differences in therapy and mortality in a multicentre study. J Antimicrob Chemother, 1 –11. http://doi.org/10.1093/jac/dkv086 17. Jacobs, D. M., Safir, M. C., Huang, D., Minhaj, F., Parker, A., & Rao, G. G. (2017). Triple combination antibiotic therapy for carbapenemase producing Klebsiella pneumoniae : a systematic review. Annals of Clinical Microbiology and Antimicrobials, 1–12. http://doi.org/10.1186/s12941-017-0249-2 18. Infectious complications after orthotopic liver transplantation. Patel G, Huprikar S.Semin Respir Crit Care Med. 2012 Feb; 33(1):111-24. Epub 2012 Mar 23. 19. Al-Hasan MN, Razonable RR, Eckel-Passow JE, Baddour LM. Incidence rate and outcome of Gram-negative bloodstream infection in solid organ transplant recipients. Am J Transplant 2009;9(4):835–843 20. Singh, N., Wagener, M. M., Obman, A., Cacciarelli, T. V., de Vera, M. E., & Gayowski, T. (2004). Bacteremias in liver transplant recipients: shift toward gram-negative bacteria as predominant pathogens. Liver transplantation, 10(7), 844-849. 21. González, L., & Cortés, J. A. (2014). Revisión sistemática de la farmacorresistencia en enterobacterias de aislamientos hospitalarios en Colombia. Biomédica, 34(2). 22. Ovalle, M. V., Saavedra, S. Y., González, M. N., Hidalgo, A. M., Duarte, C., & Beltrán, M. (2017). Resultados de la vigilancia nacional de la resistencia antimicrobiana de enterobacterias y bacilos Gram negativos no fermentadores en infecciones asociadas a la atención de salud, Colombia, 2012-2014. Biomédica, 37(4), 473-485. 23. Falagas, M. E., Tansarli, G. S., Karageorgopoulos, D. E., & Vardakas, K. Z. (2014). Deaths Attributable to Carbapenem Resistant EnterobacteriaceaeInfections. Emerging Infectious Diseases, 20(7), 1170–1175. http://doi.org/10.3201/eid2007.121004 24. Montúfar-Andrade, F. E., Mesa-Navas, M., Aguilar-Londoño, C., Saldarriaga-Acevedo, C., Quiroga-Echeverr, A., Builes-Montaño, C. E., ... & Hernández, C. (2016). Clinical experience with infections caused by carbapenemase-producing Klebsiella pneumoniae in a tertiary care teaching institution in Medellín, Colombia. Infectio, 20(1), 17-24. Repositorio EdocUR-U. Rosario Universidad del Rosario instacron:Universidad del Rosario